Novavax Inc.

(NVAX) Trade

By |

Profile

Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.

Contact Information

Website: www.novavax.com
Email: ir@novavax.com
Main Phone: +1 240 268-2000
Address: 20 Firstfield Road
State: MD
City / Town: Gaithersburg
Country: USA
Postal Code: 20878

Issuer Information

Exchange: NGS
CEO: Stanley Charles Erck
Employees: 347
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 1.60 $ 0.13 (8.84%)
Last Price 1.60 Change $ 0.13 Change % 8.84 Tick N/A
Bid 1.62 Bid Size 600.00 Ask 1.64 Ask Size 4,000.00
Open 1.60 High 1.70 Low 1.55 Prev Close 1.47
Last Trade Volume 28.5 mi 52 Wk Hi 2.75 52 Wk Low 0.96
Market Cap 612.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 382,591,799.00 EPS (TTM) -0.57 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 9
Number of Buys 4 8
Number of Sells 0 1
Net Activity 170000 119841
Last 10 Buys Shares
Gregory Glenn 1,000
Gregory Glenn 1,000
John Trizzino 1,000
Stanley Charles Erck 1,000
Gregory Glenn 1,000
Gregory Glenn 1,000
Stanley Charles Erck 1,000
Barclay A. Phillips 1,000
Michael A. Mcmanus 1,000
Stanley Charles Erck 1,000
Last 10 Sell Shares
James F. Young 1,000
James F. Young 1,000
Gary C. Evans 1,000
Gary C. Evans 1,000
Gary C. Evans 1,000
Stanley Charles Erck 1,000
Stanley Charles Erck 1,000
Gregory Glenn 1,000
John A. Herrmann 1,000
Gary C. Evans 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 1.5 1.5 1.5 1.5
Mean Target Price Estimate 3.82 3.82 3.82 3.82
Standard Deviation 2.97 2.97 2.97 2.97
Date of Most Recent Estimate 05/25/18 05/25/18 05/22/18 06/15/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 3
Moderate Buy 0 0 0 0
Hold 3 3 3 5
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 0
Mean Rec. 2.25 2.25 2.25 2.25